We Are a Leader in Oculomics
We are revolutionizing early disease detection with point-of-care teleretinal scans.
Helping Clinicians Detect Disease Early, Improve Outcomes, & Maximize Value
We operate at the convergence of MedTech (data + AI) and Healthtech (teleretinal), committed to creating next-gen population-based Oculomics solutions that enable early disease interception that offer value to primary care practices, clinical lab testing sites, retail pharmacy clinics, integrated health systems, and patients alike.
We offer a turnkey teleretinal scanning solution for point of care clinicians to better evaluate their patients.
With our unique all-in-one approach, we help clinicians meet essential quality metrics, maximize reimbursements, and most importantly, detect diseases early to reduce the long-term burden of preventable diseases.
We chose diabetic retinopathy for our first application since it is the most feared complication of diabetes.
"We made a bold decision to prioritize screening. As a physician, I will have succeeded if I can leave this world a little better than I found it. We can all take pride in the work we do here at Vitazi.ai."
Dr. Jeremy Stueven, CEO
Often, There Are No Early Symptoms of the Disease Making Annual Eye Scans Critical for Early Interception and Treatment. Patients Developing the Disease Might Even Have 20/20 Vision.
Only 50% of diabetic patients get an annual eye scanUntil recently, the only way to detect diabetic retinopathy before any noticeable symptoms was through retinal examination by a trained ophthalmologist using dilation. This is a lengthy & costly procedure that patients resist due to lack of transportation, time-off work, reluctance to have drops put in their eyes, lack of coordination between PCPs and specialists, multiple visits and co-pays, and lack of access to specialists.
M
people live with diabetes in the U.S.
%
of diabetics do not get annual diabetic eye scans.
%
of severe vision loss can be prevented with annual scans and treatment.
Our Solution to Close the Care Gap
Our Healthtech solution, Vitazi-MD™ teleretinal imaging, aims to close the care gap in diabetic retinopathy screening to prevent vision loss and blindness in patients with diabetes.
Our accurate early disease interception solutions offer healthcare professionals the critical insights they need when they need them most. Plus, our versatile platform may assist our teleretinal physicians in the detection of numerous diseases.
How Did Vitazi.ai Come About?
Created by a physician for physiciansVitazi.ai is the brainchild of Dr. Jeremy Stueven, CEO. During his tenure as an emergency room physician, he envisioned retinal scans as a new vital sign included in routine physiological measurements. Since the retina is a vital source of information on our systemic health, retinal scans can help detect several health conditions and help prevent, even reverse, the progression of disease.
Through Vitazi.ai, Dr. Stueven is implementing his vision into reality by making teleretinal scanning accessible, enabling earlier interventions, better patient outcomes, and a proactive value-based approach to healthcare.
Watch Dr. Jeremy Stueven
Mission
Our mission is to utilize Oculomics and next-generation technology to transform population health by expanding access with point-of-care vital health screenings that enable early disease interception, curb progression, and drive better health outcomes.
Vision
We envision a future where everyone has access to our transformative screening solutions, empowering proactive health insights at primary care offices, retail pharmacies, and clinical labs, leading to reliable early disease interception.
Values
We are committed to improving the delivery of healthcare through:
- Innovation
- Collaboration
- Accountability
- Transparency
- Operational Excellence
- Compassion